Injective launches Policy Institute May 21

Injective said on May 21 that it had launched the Injective Policy Institute, a Washington-based policy and research arm that will work with U.S. regulators, lawmakers and other stakeholders on rules for onchain finance. The institute’s public materials say it will focus on decentralized finance, stablecoins, tokenized assets and onchain derivatives as U.S. policymakers continue to debate how digital asset markets should be regulated. Injective, which describes itself as an American-founded crypto ecosystem and a blockchain built for finance, said the new group is meant to bring operating and technical experience into policy discussions in Washington. The institute’s website says Injective Labs, the original developer of the blockchain, is headquartered in New York City. ### What exactly did Injective launch on May 21? The May 21 announcement described the Injective Policy Institute, or IPI, as the policy and research arm of Injective. The company said the group is based in Washington, D.C., and will engage directly with regulators, lawmakers and other stakeholders on a policy framework for onchain finance in the United States. The institute’s website says its work is aimed at helping shape “a clear and workable framework” for finance built on blockchain rails in the United States. (injective.com) The site also says the group was launched to provide technical expertise, policy analysis and practical recommendations as regulators weigh how to oversee decentralized financial infrastructure. ### Which policy areas did the institute say it wants to influence? Injective said the U.S. approach to DeFi, onchain derivatives and decentralized markets “is still being written,” and argued that builders and users do not yet have a clear path to governance. (injective.com) The announcement said the institute will concentrate on areas where policymakers are already active, including stablecoin payments, decentralized lending and tokenized assets. (injectivepolicy.org) The institute’s website says “stablecoin payments, perpetual futures, decentralized lending, and tokenized assets are already live at global scale.” It also lays out four principles for its policy work: “clarity over ambiguity,” “access over exclusion,” “sovereignty over intermediation,” and “American leadership.” ### Who is running the new policy arm? John Medel was named chair of the Injective Policy Institute in the launch post. Injective said Medel leads its engagement with policymakers, regulators and industry stakeholders on blockchain and decentralized finance issues. (injective.com) Before joining Injective, Medel served as a senior public policy manager at Coinbase and previously worked as a vice president at Goldman Sachs, according to the company’s announcement. (injectivepolicy.org) The May 21 post also listed Ashok Pinto and Stacey Rolland as external advisors to the institute. ### Why is Injective making the case for a Washington presence now? The institute’s materials say other jurisdictions are moving faster than the United States to write rules for digital assets and onchain finance. (injective.com) Injective said that without a U.S. framework, the country risks losing leadership, talent and capital in the sector. The company also framed the policy effort around technologies it says are already operating at scale. Its launch post cited stablecoin payments, perpetual futures, decentralized lending and tokenized equities as examples of products already in use while regulation is still evolving. (injective.com) ### What comes next from the institute? The institute’s website says it plans to engage policymakers with policy analysis, technical expertise and practical recommendations rather than operate only as a public-facing advocacy campaign. (injectivepolicy.org) The May 21 launch materials also direct visitors to the institute’s Washington-based site for future work and contact information. As of May 23, the institute’s public pages identify Medel as chair and list its focus areas as DeFi, stablecoins, tokenized assets and onchain derivatives. (injective.com) Future updates are expected through the institute’s website and Injective’s official channels. (injectivepolicy.org)